Pharmaceutical - Anti-virals

Filter

Current filters:

Anti-virals

Popular Filters

226 to 250 of 312 results

Indonesian government overrides patents on seven HIV and hepatitis drugs

15-10-2012

In a move that was announced in early September but which just came to light last week, the government…

Anti-viralsGenericsPatentsPharmaceuticalPoliticsPricing

Australia's Benitec to acquire US RNAi firm Tacere

15-10-2012

Australia-based Benitec Biopharma (ASX: BLT) said last Friday that it has executed an agreement to acquire…

Anti-viralsBenitec BiopharmaBiotechnologyMergers & AcquisitionsPharmaceuticalTacere Therapeutics

Gilead's Truvada as HIV prevention to carry stronger FDA warning label

14-10-2012

The USA-based non-profit HIV/AIDS advocacy AIDS Healthcare Foundation (AHF) welcomed the news yesterday…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationTruvada

HIV drug nelfinavir shows efficacy in mouse models of HER2+ breast cancer

08-10-2012

The HIV protease inhibitor nelfinavir, marketed by Swiss drug major Roche as Viracept, can be used to…

Anti-viralsnelfinavirOncologyPharmaceuticalResearchRocheViracept

Achillion Pharma moves up as a contender in the HCV market, GlobalData believes

02-10-2012

On September 27, Achillion Pharmaceuticals (Nasdaq: ACHN) released news of positive results surrounding…

ACH-3102Achillion PharmaceuticalsAnti-viralsBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

Astellas to use Abbott's CMV assay for vaccine trial

06-09-2012

US health care major Abbott Laboratories (NYSE: ABT) says that it has signed an agreement to collaborate…

Abbott LaboratoriesAnti-viralsAstellas PharmaPharmaceuticalResearchTransVaxVaccines

Bristol-Myers drops hep C pill on patient safety issues

24-08-2012

US drug major Bristol-Myers Squibb (NYSE: BMY) has discontinued development of BMS-986094 (formerly known…

Anti-viralsBiotechnologyBMS-986094Bristol-Myers SquibbPharmaceuticalRegulationResearch

NanoViricides' flu drug candidates demonstrate oral effectiveness

21-08-2012

US drug developer NanoViricides (OTCBB: NNVC) says that anti-influenza drug candidates under its FluCide…

Anti-viralsFluCideNanoViricidesPharmaceuticalResearchTamiflu

AHF calls for Gilead's Quad HIV pill to be put on "prior authorization" status

19-08-2012

In what may be an unprecedented move on drug pricing and access, advocates from the AIDS Healthcare Foundation…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalPricingQuadRegulation

Idenix plunges as FDA puts clinical hold on hepatitis C drug candidate

17-08-2012

US biotech firm Idenix Pharmaceuticals (Nasdaq: IDIX) saw its shares tank 29% to $5.91 in morning trading…

Anti-viralsBiotechnologyIdenix PharmaceuticalsIDX184North AmericaPharmaceuticalRegulationResearch

Consumer groups call for fixed-dose HIV drugs in South African tenders

16-08-2012

Consumer groups Treatment Action Campaign and Medecins sans Frontiers have issued a call for the inclusion…

Anti-viralsGenericsHealthcareMarkets & MarketingPharmaceuticalPricingRest of the World

Crucell and Scripps Research discover broad-spectrum antibodies against influenza B

12-08-2012

In what is described as a landmark discovery, researchers from Crucell Holland, which became wholly-owned…

Anti-viralsBiotechnologyCrucellJohnson & JohnsonPharmaceuticalResearchVaccines

News briefs: setbacks for B-MS hep C drug; Baxter's HyQ

02-08-2012

US drug major Bristol-Myers Squibb (NYSE: BMY) has suspended study drug administration in ongoing Phase…

Anti-viralsBaxter InternationalBMS-986094Bristol-Myers SquibbHyQImmunologicalsNorth AmericaPharmaceuticalRegulationResearch

Novartis restructures deal with Idenix Pharmaceuticals

01-08-2012

USA-based Idenix Pharmaceuticals (Nasdaq: IDIX) says that Swiss drug major Novartis (NOVN: VX) has restructured…

Anti-viralsIdenix PharmaceuticalsLicensingNovartisPharmaceuticaltelbivudine

Middle-income countries flex muscles to overcome patents in face of unaffordable drug prices

29-07-2012

Middle-income countries are increasingly taking measures to overcome the patents that price drugs out…

Anti-viralsGenericsGlobalPatentsPharmaceuticalPricing

Pioneering study shows vorinostat can purge dormant HIV

26-07-2012

Researchers from the University of North Carolina at Chapel Hill have published pioneering research showing…

Anti-viralsMerck & CoPharmaceuticalResearchvorinostatZolinza

UK to implement child flu vaccines program

25-07-2012

UK Health Secretary Andrew Lansley yesterday accepted recommendations from UK immunization experts to…

Anti-viralsAstraZenecaFluenzHealthcarePharmaceuticalVaccines

More than 150 ARVs available through PEPFAR for global HIV/AIDS relief

24-07-2012

US Food and Drug Administration Commissioner Margaret Hamburg says that the agency has approved or tentatively…

Anti-viralsGenericsGlobalPharmaceuticalRegulation

Merck & Co in-licenses Chimerix antiviral; Fiocruz to make ARVs in Africa

24-07-2012

USA-based Chimerix, a venture-funded biotech focused on developing novel oral antivirals, has announced…

Anti-viralsChimerixCMX001CMX157FiocruzGlobalLicensingMarkets & MarketingMerck & CoPharmaceuticalRest of the World

DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination

24-07-2012

Coinciding with the XIX International AIDS Conference in Washington DC, the Drugs for Neglected Diseases…

Anti-viralsCiplaGenericsGlobalPharmaceuticalResearch

US govt plans innovative public-private partnerships to turn the tide in fight against HIV/AIDS

23-07-2012

In a speech at the opening session of the XIX International AIDS Conference (AIDS 2012) in Washington…

Anti-viralsBiotechnologyHealthcareNorth AmericaPharmaceutical

Domestic HIV funding outpaces international investments

19-07-2012

A new report by the Joint United Nations Program on HIV/AIDS (UNAIDS) shows that domestic funding for…

Anti-viralsFinancialGlobalHealthcarePharmaceutical

226 to 250 of 312 results

Parexel

Parexel

Back to top